文献速递慢性肾脏病急性肾损伤

肾切除术后临床显著CKD风险分层的简易临床工具:开发与多国验证

A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation.
PubMed 文献 · J Am Soc Nephrol · 2020-04-01

研究基于澳大利亚昆士兰699例肾癌患者开发简易评分工具,并在澳大利亚维多利亚423例及昆士兰、苏格兰、英格兰单中心队列中验证。主要终点为肾切除术后12个月新发eGFR<45 ml/min per 1.73 m2。结果显示四层风险(可忽略、低、中、高)的绝对风险分别为<2%、3%~14%、21%~26%、46%~69%,可忽略风险类阴性预测值98.9%,c统计量0.84~0.88。

要点

  • 基于年龄≥65岁、糖尿病、术前eGFR和肾切除类型四个参数构建简易评分。
  • 四层风险分层可重复区分肾切除术后临床显著CKD风险。
  • 可忽略风险类对临床显著CKD的阴性预测值达98.9%。

核心结论

  • 简易评分系统可基于易得参数可重复地对肾切除术后CKD风险进行分层。
  • 该工具对CKD风险的定量评估有助于肾肿瘤管理决策和医患共享决策。

研究设计与样本

  • 在澳大利亚昆士兰699例肾癌患者人群队列中测试模型,并在澳大利亚维多利亚423例人群队列及昆士兰、苏格兰、英格兰单中心队列中验证。
  • 纳入标准为具有两个功能肾脏且术前eGFR ≥60 ml/min per 1.73 m2。
  • 主要结局为肾切除术后12个月新发eGFR <45 ml/min per 1.73 m2。
  • 使用预设预测因子(年龄≥65岁、糖尿病、术前eGFR、肾切除类型(部分/根治))拟合逻辑回归模型,并将患者按风险程度分组(可忽略、低、中、高)。

主要发现

  • 可忽略、低、中、高四层风险的3b期及以上CKD绝对风险分别为<2%、3%~14%、21%~26%、46%~69%。
  • 可忽略风险类对临床显著CKD的阴性预测值为98.9%。
  • 该评分在推导和验证队列中的c统计量范围为0.84~0.88。

关键数值与推荐

  • 风险分层基于年龄≥65岁、糖尿病、术前eGFR和肾切除类型(部分/根治)四个预设预测因子。
  • 四层风险对应的3b期及以上CKD绝对风险:可忽略<2%、低3%~14%、中21%~26%、高46%~69%。
  • 可忽略风险类阴性预测值98.9%,c统计量0.84~0.88。

临床怎么用

  • 可利用年龄、糖尿病、术前eGFR和肾切除类型简易评分对肾切除术后CKD风险进行分层。
  • 风险分层结果可与其它因素权衡,辅助肾肿瘤管理规划和医患共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinically significant CKD following surgery for kidney cancer is associated with increased morbidity and mortality, but identifying patients at increased CKD risk remains difficult. Simple methods to stratify risk of clinically significant CKD after nephrectomy are needed. METHODS: To develop a tool for stratifying patients' risk of CKD arising after surgery for kidney cancer, we tested models in a population-based cohort of 699 patients with kidney cancer in Queensland, Australia (2012-2013). We validated these models in a population-based cohort of 423 patients from Victoria, Australia, and in patient cohorts from single centers in Queensland, Scotland, and England. Eligible patients had two functioning kidneys and a preoperative eGFR ≥60 ml/min per 1.73 m2. The main outcome was incident eGFR <45 ml/min per 1.73 m2 at 12 months postnephrectomy. We used prespecified predictors-age ≥65 years old, diabetes mellitus, preoperative eGFR, and nephrectomy type (partial/radical)-to fit logistic regression models and grouped patients according to degree of risk of clinically significant CKD (negligible, low, moderate, or high risk). RESULTS: Absolute risks of stage 3b or higher CKD were <2%, 3% to 14%, 21% to 26%, and 46% to 69% across the four strata of negligible, low, moderate, and high risk, respectively. The negative predictive value of the negligible risk category was 98.9% for clinically significant CKD. The c statistic for this score ranged from 0.84 to 0.88 across derivation and validation cohorts. CONCLUSIONS: Our simple scoring system can reproducibly stratify postnephrectomy CKD risk on the basis of readily available parameters. This clinical tool's quantitative assessment of CKD risk may be weighed against other considerations when planning management of kidney tumors and help inform shared decision making between clinicians and patients.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ellis RJ, Del Vecchio SJ, Gallagher KMJ, et al. A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation. J Am Soc Nephrol. 2020. PMID: 32238473. doi:10.1681/ASN.2019121328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。